Discovery and evaluation of PRL trimer disruptors for novel anticancer agents

Yunpeng Bai, Zhi Hong Yu, Zhong-Yin Zhang

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Overexpression of PRL phosphatases (PRL1, PRL2, and PRL3) has been found in a variety of late-stage tumors and their distant metastatic sites. Therefore, the oncogenic PRL phosphatases represent intriguing targets for cancer therapy. There is considerable interest in identifying small molecule inhibitors targeting PRLs as novel anticancer agents. However, it has been difficult to acquire phosphatase activity-based PRL inhibitors due to the unusual wide and shallow catalytic pockets of PRLs revealed by crystal structure studies. Here, we present a novel method to identify PRL1 inhibitors by targeting the PRL1 trimer interface and the procedure to characterize their biochemical and cellular activity.

Original languageEnglish (US)
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages121-138
Number of pages18
Volume1447
DOIs
StatePublished - 2016

Publication series

NameMethods in Molecular Biology
Volume1447
ISSN (Print)10643745

Fingerprint

Phosphoric Monoester Hydrolases
Antineoplastic Agents
Neoplasms
Therapeutics

Keywords

  • MTT assay
  • PRL phosphatases
  • Transwell migration assay
  • Trimerization
  • Virtual screening
  • Wound healing assay

ASJC Scopus subject areas

  • Medicine(all)
  • Molecular Biology
  • Genetics

Cite this

Bai, Y., Yu, Z. H., & Zhang, Z-Y. (2016). Discovery and evaluation of PRL trimer disruptors for novel anticancer agents. In Methods in Molecular Biology (Vol. 1447, pp. 121-138). (Methods in Molecular Biology; Vol. 1447). Humana Press Inc.. https://doi.org/10.1007/978-1-4939-3746-2_8

Discovery and evaluation of PRL trimer disruptors for novel anticancer agents. / Bai, Yunpeng; Yu, Zhi Hong; Zhang, Zhong-Yin.

Methods in Molecular Biology. Vol. 1447 Humana Press Inc., 2016. p. 121-138 (Methods in Molecular Biology; Vol. 1447).

Research output: Chapter in Book/Report/Conference proceedingChapter

Bai, Y, Yu, ZH & Zhang, Z-Y 2016, Discovery and evaluation of PRL trimer disruptors for novel anticancer agents. in Methods in Molecular Biology. vol. 1447, Methods in Molecular Biology, vol. 1447, Humana Press Inc., pp. 121-138. https://doi.org/10.1007/978-1-4939-3746-2_8
Bai Y, Yu ZH, Zhang Z-Y. Discovery and evaluation of PRL trimer disruptors for novel anticancer agents. In Methods in Molecular Biology. Vol. 1447. Humana Press Inc. 2016. p. 121-138. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-4939-3746-2_8
Bai, Yunpeng ; Yu, Zhi Hong ; Zhang, Zhong-Yin. / Discovery and evaluation of PRL trimer disruptors for novel anticancer agents. Methods in Molecular Biology. Vol. 1447 Humana Press Inc., 2016. pp. 121-138 (Methods in Molecular Biology).
@inbook{a2051d9e7bdb4cafa78e23f19f3308ac,
title = "Discovery and evaluation of PRL trimer disruptors for novel anticancer agents",
abstract = "Overexpression of PRL phosphatases (PRL1, PRL2, and PRL3) has been found in a variety of late-stage tumors and their distant metastatic sites. Therefore, the oncogenic PRL phosphatases represent intriguing targets for cancer therapy. There is considerable interest in identifying small molecule inhibitors targeting PRLs as novel anticancer agents. However, it has been difficult to acquire phosphatase activity-based PRL inhibitors due to the unusual wide and shallow catalytic pockets of PRLs revealed by crystal structure studies. Here, we present a novel method to identify PRL1 inhibitors by targeting the PRL1 trimer interface and the procedure to characterize their biochemical and cellular activity.",
keywords = "MTT assay, PRL phosphatases, Transwell migration assay, Trimerization, Virtual screening, Wound healing assay",
author = "Yunpeng Bai and Yu, {Zhi Hong} and Zhong-Yin Zhang",
year = "2016",
doi = "10.1007/978-1-4939-3746-2_8",
language = "English (US)",
volume = "1447",
series = "Methods in Molecular Biology",
publisher = "Humana Press Inc.",
pages = "121--138",
booktitle = "Methods in Molecular Biology",

}

TY - CHAP

T1 - Discovery and evaluation of PRL trimer disruptors for novel anticancer agents

AU - Bai, Yunpeng

AU - Yu, Zhi Hong

AU - Zhang, Zhong-Yin

PY - 2016

Y1 - 2016

N2 - Overexpression of PRL phosphatases (PRL1, PRL2, and PRL3) has been found in a variety of late-stage tumors and their distant metastatic sites. Therefore, the oncogenic PRL phosphatases represent intriguing targets for cancer therapy. There is considerable interest in identifying small molecule inhibitors targeting PRLs as novel anticancer agents. However, it has been difficult to acquire phosphatase activity-based PRL inhibitors due to the unusual wide and shallow catalytic pockets of PRLs revealed by crystal structure studies. Here, we present a novel method to identify PRL1 inhibitors by targeting the PRL1 trimer interface and the procedure to characterize their biochemical and cellular activity.

AB - Overexpression of PRL phosphatases (PRL1, PRL2, and PRL3) has been found in a variety of late-stage tumors and their distant metastatic sites. Therefore, the oncogenic PRL phosphatases represent intriguing targets for cancer therapy. There is considerable interest in identifying small molecule inhibitors targeting PRLs as novel anticancer agents. However, it has been difficult to acquire phosphatase activity-based PRL inhibitors due to the unusual wide and shallow catalytic pockets of PRLs revealed by crystal structure studies. Here, we present a novel method to identify PRL1 inhibitors by targeting the PRL1 trimer interface and the procedure to characterize their biochemical and cellular activity.

KW - MTT assay

KW - PRL phosphatases

KW - Transwell migration assay

KW - Trimerization

KW - Virtual screening

KW - Wound healing assay

UR - http://www.scopus.com/inward/record.url?scp=84981747011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981747011&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-3746-2_8

DO - 10.1007/978-1-4939-3746-2_8

M3 - Chapter

VL - 1447

T3 - Methods in Molecular Biology

SP - 121

EP - 138

BT - Methods in Molecular Biology

PB - Humana Press Inc.

ER -